We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

AbbVie Inc. beat revenue & EPS estimates, raised guidance due to Skyrizi & Rinvoq growth. Immunology shines; future ...

We recently published a list of the 15 Best Dividend Stocks to Buy for Long-Term Passive Income. In this article, we are ...

Clinical academia is on a steep decline globally. In the UK, a 6% reduction in the number of clinical academics since 2012 has been reported, with the number of senior lecturer level researchers ...

Sylvie Grégoire, Chair of Abivax Board of Directors, commented: “We are delighted to welcome Dominik to the Board at such a pivotal moment for Abivax. His extensive background in global medical ...

In addition, Paul Stoffels, who led Galapagos’ transformation into a cell therapy company, will retire from his role within ...

A completed Request for private sector organization screening (PSOS) form is required in specific instances to sponsor eligible organizations for a security clearance with the Contract Security ...

Financial giants have made a conspicuous bearish move on AbbVie. Our analysis of options ... 20-year pro options trader reveals his one-line chart technique that shows when to buy and sell.

Looking at the universe of stocks we cover at Dividend Channel, on 4/15/25, Buckle, Inc. (Symbol: BKE), AbbVie Inc (Symbol: ABBV), and Abbott Laboratories (Symbol: ABT) will all trade ex-dividend ...

Microsoft is reportedly considering another round of job cuts in May, driven by a push for greater efficiency and a leaner organizational structure. Sources indicate the cuts will likely target ...

AbbVie stock outperformed S&P 500 with a +16% to 9.41% return since November 2023, despite Humira revenue declining 38% to $8.99 billion. Immunology drugs Skyrizi and Rinvoq grew over 50% year ...